Inpharma Weekly

, Volume 1247, Issue 1, pp 7–7 | Cite as

IFN-β cost effective for MS after all?

Review
  • 4 Downloads

Keywords

Multiple Sclerosis Standard Care Annual Cost Societal Perspective Disability Progression 

Copyright information

© Adis International Ltd 2000

Personalised recommendations